163 related articles for article (PubMed ID: 30867288)
1. RBFox2-miR-34a-Jph2 axis contributes to cardiac decompensation during heart failure.
Hu J; Gao C; Wei C; Xue Y; Shao C; Hao Y; Gou LT; Zhou Y; Zhang J; Ren S; Chen J; Wang Y; Fu XD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6172-6180. PubMed ID: 30867288
[TBL] [Abstract][Full Text] [Related]
2. Suppression of RBFox2 by Multiple MiRNAs in Pressure Overload-Induced Heart Failure.
Gu M; Zhao Y; Wang H; Cheng W; Liu J; Ouyang K; Wei C
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674797
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
Bernardo BC; Ooi JY; Matsumoto A; Tham YK; Singla S; Kiriazis H; Patterson NL; Sadoshima J; Obad S; Lin RC; McMullen JR
J Physiol; 2016 Oct; 594(20):5959-5974. PubMed ID: 27270487
[TBL] [Abstract][Full Text] [Related]
4. SPEG (Striated Muscle Preferentially Expressed Protein Kinase) Is Essential for Cardiac Function by Regulating Junctional Membrane Complex Activity.
Quick AP; Wang Q; Philippen LE; Barreto-Torres G; Chiang DY; Beavers D; Wang G; Khalid M; Reynolds JO; Campbell HM; Showell J; McCauley MD; Scholten A; Wehrens XH
Circ Res; 2017 Jan; 120(1):110-119. PubMed ID: 27729468
[TBL] [Abstract][Full Text] [Related]
5. Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases.
Ooi JYY; Bernardo BC; Singla S; Patterson NL; Lin RCY; McMullen JR
RNA Biol; 2017 May; 14(5):500-513. PubMed ID: 27124358
[TBL] [Abstract][Full Text] [Related]
6. RBFox2 Binds Nascent RNA to Globally Regulate Polycomb Complex 2 Targeting in Mammalian Genomes.
Wei C; Xiao R; Chen L; Cui H; Zhou Y; Xue Y; Hu J; Zhou B; Tsutsui T; Qiu J; Li H; Tang L; Fu XD
Mol Cell; 2016 Jun; 62(6):875-889. PubMed ID: 27211866
[TBL] [Abstract][Full Text] [Related]
7. RBFOX2 is required for establishing RNA regulatory networks essential for heart development.
Verma SK; Deshmukh V; Thatcher K; Belanger KK; Rhyner AM; Meng S; Holcomb RJ; Bressan M; Martin JF; Cooke JP; Wythe JD; Widen SG; Lincoln J; Kuyumcu-Martinez MN
Nucleic Acids Res; 2022 Feb; 50(4):2270-2286. PubMed ID: 35137168
[TBL] [Abstract][Full Text] [Related]
8. Nuclear localization of a novel calpain-2 mediated junctophilin-2 C-terminal cleavage peptide promotes cardiomyocyte remodeling.
Lahiri SK; Quick AP; Samson-Couterie B; Hulsurkar M; Elzenaar I; van Oort RJ; Wehrens XHT
Basic Res Cardiol; 2020 Jun; 115(4):49. PubMed ID: 32592107
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-34a targets regulator of calcineurin 1 to modulate endothelial inflammation after fetal cardiac bypass in goat placenta.
Yuan HY; Zhou CB; Chen JM; Liu XB; Wen SS; Xu G; Zhuang J
Placenta; 2017 Mar; 51():49-56. PubMed ID: 28292468
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of the hypoxia-induced miR-34a protects cardiomyocytes through maintenance of glucose metabolism.
Wang ZC; Wang ZZ; Ma HJ; Wang CC; Wang HT
Biochem Biophys Res Commun; 2018 Apr; 498(3):375-381. PubMed ID: 28709867
[TBL] [Abstract][Full Text] [Related]
11. An SRF/miR-1 axis regulates NCX1 and annexin A5 protein levels in the normal and failing heart.
Tritsch E; Mallat Y; Lefebvre F; Diguet N; Escoubet B; Blanc J; De Windt LJ; Catalucci D; Vandecasteele G; Li Z; Mericskay M
Cardiovasc Res; 2013 Jun; 98(3):372-80. PubMed ID: 23436819
[TBL] [Abstract][Full Text] [Related]
12. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-34a modulates the Notch signaling pathway in mice with congenital heart disease and its role in heart development.
Wu KH; Xiao QR; Yang Y; Xu JL; Zhang F; Liu CM; Zhang ZM; Lu YQ; Huang NP
J Mol Cell Cardiol; 2018 Jan; 114():300-308. PubMed ID: 29175286
[TBL] [Abstract][Full Text] [Related]
14. Repression of the Central Splicing Regulator RBFox2 Is Functionally Linked to Pressure Overload-Induced Heart Failure.
Wei C; Qiu J; Zhou Y; Xue Y; Hu J; Ouyang K; Banerjee I; Zhang C; Chen B; Li H; Chen J; Song LS; Fu XD
Cell Rep; 2015 Mar; 10(9):1521-1533. PubMed ID: 25753418
[TBL] [Abstract][Full Text] [Related]
15. Junctophilin-2 is necessary for T-tubule maturation during mouse heart development.
Reynolds JO; Chiang DY; Wang W; Beavers DL; Dixit SS; Skapura DG; Landstrom AP; Song LS; Ackerman MJ; Wehrens XH
Cardiovasc Res; 2013 Oct; 100(1):44-53. PubMed ID: 23715556
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial Infarction.
Yang Y; Cheng HW; Qiu Y; Dupee D; Noonan M; Lin YD; Fisch S; Unno K; Sereti KI; Liao R
Circ Res; 2015 Aug; 117(5):450-9. PubMed ID: 26082557
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-34a promotes cardiomyocyte apoptosis post myocardial infarction through down-regulating aldehyde dehydrogenase 2.
Fan F; Sun A; Zhao H; Liu X; Zhang W; Jin X; Wang C; Ma X; Shen C; Zou Y; Hu K; Ge J
Curr Pharm Des; 2013; 19(27):4865-73. PubMed ID: 23323620
[TBL] [Abstract][Full Text] [Related]
18. RBFOX2 is critical for maintaining alternative polyadenylation patterns and mitochondrial health in rat myoblasts.
Cao J; Verma SK; Jaworski E; Mohan S; Nagasawa CK; Rayavara K; Sooter A; Miller SN; Holcomb RJ; Powell MJ; Ji P; Elrod ND; Yildirim E; Wagner EJ; Popov V; Garg NJ; Routh AL; Kuyumcu-Martinez MN
Cell Rep; 2021 Nov; 37(5):109910. PubMed ID: 34731606
[TBL] [Abstract][Full Text] [Related]
19. MiR-34a Enhances Chondrocyte Apoptosis, Senescence and Facilitates Development of Osteoarthritis by Targeting DLL1 and Regulating PI3K/AKT Pathway.
Zhang W; Hsu P; Zhong B; Guo S; Zhang C; Wang Y; Luo C; Zhan Y; Zhang C
Cell Physiol Biochem; 2018; 48(3):1304-1316. PubMed ID: 30048987
[TBL] [Abstract][Full Text] [Related]
20. Diabetes induces the activation of pro-ageing miR-34a in the heart, but has differential effects on cardiomyocytes and cardiac progenitor cells.
Fomison-Nurse I; Saw EEL; Gandhi S; Munasinghe PE; Van Hout I; Williams MJA; Galvin I; Bunton R; Davis P; Cameron V; Katare R
Cell Death Differ; 2018 Jul; 25(7):1336-1349. PubMed ID: 29302057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
